We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01733576
Recruitment Status : Completed
First Posted : November 27, 2012
Last Update Posted : July 23, 2015
Sponsor:
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales

Brief Summary:
This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.

Condition or disease Intervention/treatment Phase
Verbal Learning and Memory Device: HD-tDCS Early Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)
Primary Completion Date : March 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Memory
U.S. FDA Resources

Arm Intervention/treatment
Sham Comparator: Sham HD-tDCS Device: HD-tDCS
Active Comparator: Active HD-tDCS 1 Device: HD-tDCS
Active Comparator: Active HD-tDCS 2 Device: HD-tDCS
Active Comparator: Active HD-tDCS 3 Device: HD-tDCS



Primary Outcome Measures :
  1. Ray Auditory Verbal Learning Test (RAVLT)


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages 18 - 40 years
  • Right-handed

Exclusion Criteria:

  • concurrent medication likely to affect mental performance
  • current history of drug or alcohol abuse or dependence
  • any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01733576


Locations
Australia, New South Wales
Black Dog Institute
Sydney, New South Wales, Australia, 2031
Sponsors and Collaborators
The University of New South Wales

Responsible Party: Melissa Pigot, Research Assistant, The University of New South Wales
ClinicalTrials.gov Identifier: NCT01733576     History of Changes
Other Study ID Numbers: CB64
First Posted: November 27, 2012    Key Record Dates
Last Update Posted: July 23, 2015
Last Verified: July 2015